MedPath
FDA Approval

Methocarbamol

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
December 18, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Methocarbamol(100 mg in 1 mL)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Somerset Therapeutics, LLC

079947873

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Somerset Therapeutics Limited

Somerset Therapeutics, LLC

Somerset Therapeutics, LLC

677236695

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Methocarbamol

Product Details

NDC Product Code
70069-101
Application Number
ANDA207522
Marketing Category
ANDA (C73584)
Route of Administration
INTRAMUSCULAR, INTRAVENOUS
Effective Date
December 18, 2023
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
Code: 125OD7737XClass: ACTIBQuantity: 100 mg in 1 mL
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
POLYETHYLENE GLYCOL 300Inactive
Code: 5655G9Y8AQClass: IACTQuantity: 0.5 mL in 1 mL
WATERInactive
Code: 059QF0KO0RClass: IACT
© Copyright 2025. All Rights Reserved by MedPath